0001609351-19-000008.txt : 20190108
0001609351-19-000008.hdr.sgml : 20190108
20190108163038
ACCESSION NUMBER: 0001609351-19-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190104
FILED AS OF DATE: 20190108
DATE AS OF CHANGE: 20190108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mehra Anand
CENTRAL INDEX KEY: 0001590102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36819
FILM NUMBER: 19516282
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spark Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609351
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462654405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 888-772-7560
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
wf-form4_154698301969473.xml
FORM 4
X0306
4
2019-01-04
0
0001609351
Spark Therapeutics, Inc.
ONCE
0001590102
Mehra Anand
SOFINNOVA INVESTMENTS, INC.
3000 SAND HILL ROAD, 4-250
MENLO PARK
CA
94025
1
0
0
0
Common Stock
2019-01-04
4
M
0
37203
3.45
A
38703
D
Common Stock
481270
I
See Footnote
Stock Option (right to buy)
3.45
2019-01-04
4
M
0
37203
0
D
2024-08-11
Common Stock
37203.0
0
D
The securities are owned directly by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII"), the general partner of SVP VIII, and Anand Mehra, a director of the Issuer, James I. Healy, and Michael Powell, the managing members of SM VIII, may be deemed to have shared voting and dispositive power over the shares owned by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares owned by SVP VIII except to the extent of any pecuniary interest therein.
This option was granted on August 11, 2014 and vests over four years, with 25% of the shares underlying the option vesting on May 24, 2015, and the remainder vesting quarterly thereafter.
The securities are owned directly by Dr. Mehra.
/s/ Nathalie Auber, attorney-in-fact for Anand Mehra
2019-01-08